Relmada Therapeutics Inc
RLMD
$4.33+2.49%
Delayed · as of Sep 17, 2026, 12:02 PM ET
Mkt cap
$692.28M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-0.32
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Use this RLMD research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RLMD income, balance, and cash tables.
Relmada Therapeutics Inc (RLMD) is a biotechnology company in the Healthcare sector.
Latest cached Relmada Therapeutics Inc (RLMD) net income for FY2025 was -$57.4M. Statements: https://lician.com/financials/rlmd
Relmada Therapeutics Inc (RLMD) market capitalization is $692.3M on the latest cached snapshot.
Relmada Therapeutics Inc (RLMD) cached previous close $4.22; day range $4.25 – $4.39; volume 205,665. Session quote: https://lician.com/quote/rlmd
Relmada Therapeutics Inc (RLMD) latest cached earnings event is "RLMD earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached RLMD filing is 8-K · Sep 8, 2026. Filings: https://lician.com/sec/rlmd